Diethylene glycol monoethyl ether-mediated nanostructured lipid carriers enhance trans-ferulic acid delivery by Caco-2 cells superior to solid lipid nanoparticles

Zhang, Hongyu; Guo, Jingwen; Wang, Zhi; Wang, Na; Feng, Nianping; Zhang, Yongtai

doi:10.2478/acph-2023-0009

Abstract

This work aimed to compare the performance of trans-ferulic acid-encapsulated nanostructured lipid carriers (NLCs) and solid lipid nanoparticles (SLNs) for transport by Caco-2 cells. The NLC particles (diameter: 102.6 nm) composed of Compritol^® 888 ATO, ethyl oleate, Cremophor^® EL, and Transcutol^® P were larger than the SLNs (diameter: 86.0 nm) formed without liquid lipid (ethyl oleate), and the former had a higher encapsulation efficiency for trans-ferulic acid (p < 0.05). In vitro cultured Caco-2 cell transport was used to simulate intestinal absorption, and the cellular uptake of NLCs was higher than that of SLNs (p < 0.05). Compared to SLNs, NLCs greatly enhanced trans-ferulic acid permeation through the Millicell^TM membrane (p < 0.05). This work confirms that NLCs have better properties than SLNs in terms of increasing drug transport by Caco-2 cells. This helps to comprehend the approach by which NLC-mediated oral bioavailability of trans-ferulic acid is better than that mediated by SLNs, as shown in our previous report.

References

1. Y. Liu, Z. Jiang, X. Hou, X. Xie, J. Shi, J. Shen, Y. He, Z. Wang and N. Feng, Functional lipid polymeric nanoparticles for oral drug delivery: Rapid mucus penetration and improved cell entry and cellular transport, Nanomedicine 21 (2019) Article ID 102075; https://doi.org/10.1016/j.nano.2019.10207531377378
Search in Google Scholar Back to article
2. J. Akbari, M. Saeedi, F. Ahmadi, S. M. H. Hashemi, A. Babaei, S. Yaddollahi, S. S. Rostamkalaei, K. Asare-Addo and A. Nokhodchi, Solid lipid nanoparticles and nanostructured lipid carriers: A review of the methods of manufacture and routes of administration, Pharm Dev. Technol. 27(5) (2022) 525–544; https://doi.org/10.1080/10837450.2022.208455435635506
Search in Google Scholar Back to article
3. Y. R. Neupane, M. D. Sabir, N. Ahmad, M. Ali and K. Kohli, Lipid drug conjugate nanoparticle as a novel lipid nanocarrier for the oral delivery of decitabine: ex vivo gut permeation studies, Nano-technology 24(41) (2013) Article ID 415102; https://doi.org/10.1088/0957-4484/24/41/41510224061410
Search in Google Scholar Back to article
4. Q. Xia, A. Saupe, R. H. Müller and E. B. Souto, Nanostrucured lipid carriers as novel carrier for sunscreen formulations, Int. J. Cosmet. Sci. 29(6) (2007) 473–482; https://doi.org/10.1111/j.1468-2494.2007.00410.x18489386
Search in Google Scholar Back to article
5. R. Augustine, A. A. Mamun, A. Hasan, S. A. Salam, R. Chandrasekaran, R. Ahmed and A. S. Thakor, Imaging cancer cells with nanostructures: Prospects of nanotechnology driven non-invasive cancer diagnosis, Adv. Colloid Interface Sci. 294 (2021) Article ID 102457; https://doi.org/10.1016/j.cis.2021.10245734144344
Search in Google Scholar Back to article
6. H. Liu, Z. Cai, F. Wang, L. Hong, L. Deng, J. Zhong, Z. Wang and W. Cui, Colon-targeted adhesive hydrogel microsphere for regulation of gut immunity and flora, Adv. Sci. (Weinheim) 8(18) (2021) e2101619 (12 pages); https://doi.org/10.1002/advs.202101619845627334292669
Search in Google Scholar Back to article
7. X. Zheng, C. Qiu, J. Long, A. Jiao, X. Xu, Z. Jin and J. Wang, Preparation and characterization of porous starch/beta-cyclodextrin microsphere for loading curcumin: Equilibrium, kinetics and mechanism of adsorption, Food Biosci. 41 (2021) Article ID 101081; https://doi.org/10.1016/j.fbio.2021.101081
Search in Google Scholar Back to article
8. M. Frühbauerová, L. Červenka, T. Hájek, M. Pouzar and J. Palarčík, Bioaccessibility of phenolics from carob (Ceratonia siliqua L.) pod powder prepared by cryogenic and vibratory grinding, Food Chem. 377 (2022) Article ID 131968; https://doi.org/10.1016/j.foodchem.2021.13196834995960
Search in Google Scholar Back to article
9. T. Peng, Y. Wang, T. Yang, F. Wang, J. Luo and Y. Zhang, Physiological and biochemical responses, and comparative transcriptome profiling of two Angelica sinensis cultivars under enhanced ultra-violet-B radiation, Front Plant. Sci. 12 (2021) Article ID 805407 (18 pages); https://doi.org/10.3389/fpls.2021.805407871892034975996
Search in Google Scholar Back to article
10. Y. Zhang, Z. Li, K. Zhang, G. Yang, Z. Wang, J. Zhao, R. Hu and N. Feng, Ethyl oleate-containing nanostructured lipid carriers improve oral bioavailability of trans-ferulic acid ascompared with conventional solid lipid nanoparticles, Int. J. Pharm. 511(1) (2016) 57–64; https://doi.org/10.1016/j.ijpharm.2016.06.13127374194
Search in Google Scholar Back to article
11. R. F. S. Gonçalves, J. T. Martins, L. Abrunhosa, J. Baixinho, A. A. Matias, A. A. Vicente and A. C. Pinheiro, Lipid-based nanostructures as a strategy to enhance curcumin bioaccessibility: Behavior under digestion and cytotoxicity assessment, Food Res. Int. 143 (2021) Article ID 110278; https://doi.org/10.1016/j.foodres.2021.11027833992378
Search in Google Scholar Back to article
12. E. T. Rodrigues, S. F. Nascimento, C. L. Pires, L. P. Godinho, C. Churro, M. J. Moreno and M. A. Pardal, Determination of intestinal absorption of the paralytic shellfish toxin GTX-5 using the Caco-2 human cell model, Environ. Sci. Pollut Res. Int. 28(47) (2021) 67256–67266; https://doi.org/10.1007/s11356-021-15342-y34247356
Search in Google Scholar Back to article
13. S. Youhanna and V. M. Lauschke, The past, present and future of intestinal in vitro cell systems for drug absorption studies, J. Pharm. Sci. 110(1) (2021) 50–65; https://doi.org10.1016/j.xphs.2020.07.00110.1016/j.xphs.2020.07.001
Search in Google Scholar Back to article
14. R. Hu, S. Liu, G. Anwaier, Q. Wang, W. Shen, Q. Shen and R. Qi, Formulation and intestinal absorption of naringenin loaded nanostructured lipid carrier and its inhibitory effects on nonalcoholic fatty liver disease, Nanomedicine 32 (2021) Article ID 102310; https://doi.org/10.1016/j.nano.2020.10231033184021
Search in Google Scholar Back to article
15. Q. Yu, X. Hu, Y. Ma, Y. Xie, Y. Lu, J. Qi, L. Xiang, F. Li and W. Wu, Lipids-based nanostructured lipid carriers (NLCs) for improved oral bioavailability of sirolimus, Drug Deliv. 23(4) (2016) 1469–1475; https://doi.org/10.3109/10717544.2016.115374427187522
Search in Google Scholar Back to article
16. J. Akbari, M. Saeedi, F. Ahmadi, S. Hashemi, A. Babaei, S. Yaddollahi, S. S. Rostamkalaei, K. Asare-Addo and A. Nokhodchi, Solid lipid nanoparticles and nanostructured lipid carriers: A review of the methods of manufacture and routes of administration, Pharm. Dev. Technol. 27(5) (2022) 525–544; https://doi.org/10.1080/10837450.2022.208455435635506
Search in Google Scholar Back to article
17. Z. Cheng, Y. Li, K. Wang, X. Zhu, P. Tharkar, W. Shu, T. Zhang, S. Zeng, L. Zhu, M. Murray, W. Chrzanowski and F. Zhou, Compritol solid lipid nanoparticle formulations enhance the protective effect of betulinic acid derivatives in human Müller cells against oxidative injury, Exp. Eye Res. 215 (2022) Article ID 108906; https://doi.org/10.1016/j.exer.2021.10890634953864
Search in Google Scholar Back to article
18. V. Pokharkar, A. Patil-Gadhe and G. Kaur, Physicochemical and pharmacokinetic evaluation of rosuvastatin loaded nanostructured lipid carriers: influence of long- and medium-chain fatty acid mixture, J. Pharm. Investig. 48 (2018) 465–476; https://doi.org/10.1007/s40005-017-0342-8
Search in Google Scholar Back to article
19. H. Shete, S. Chatterjee, A. De and V. Patravale, Long chain lipid based tamoxifen NLC. Part II: pharmacokinetic, biodistribution and in vitro anticancer efficacy studies, Int. J. Pharm. 454(1) (2013) 584–592; https://doi.org/10.1016/j.ijpharm.2013.03.03623535344
Search in Google Scholar Back to article
20. P. Ganesan, P. Ramalingam, G. Karthivashan, Y. T. Ko and D. K. Choi, Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases, Int. J. Nanomedicine 13 (2018) 1569–1583; https://doi.org/10.2147/IJN.S155593585881929588585
Search in Google Scholar Back to article
21. M. Elmowafy, K. Shalaby, H. M. Ali, N. K. Alruwaili, A. Salama, M. F. Ibrahim, M. A. Akl and T. A. Ahmed, Impact of nanostructured lipid carriers on dapsone delivery to the skin: in vitro and in vivo studies, Int. J. Pharm. 572 (2019) Article ID 118781; https://doi.org/10.1016/j.ijpharm.2019.11878131715347
Search in Google Scholar Back to article
22. S. Haddadzadegan, F. Dorkoosh and A. Bernkop-Schnürch, Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers, Adv. Drug Deliv. Rev. 182 (2022) Article ID 114097 (26 pages); https://doi.org/10.1016/j.addr.2021.11409734999121
Search in Google Scholar Back to article
23. Y. Zhang, Z. Li, K. Zhang, G. Yang, Z. Wang, J. Zhao, R. Hu and N. Feng, Ethyl oleate-containing nanostructured lipid carriers improve oral bioavailability of trans-ferulic acid as compared with conventional solid lipid nanoparticles, Int. J. Pharm. 511(1) (2016) 57–64; https://doi.org/10.1016/j.ijpharm.2016.06.13127374194
Search in Google Scholar Back to article
24. L. Zhou, Y. Chen, Z. Zhang, J. He, M. Du and Q. Wu, Preparation of tripterine nanostructured lipid carriers and their absorption in rat intestine, Pharmazie 67(4) (2012) 304–310; https://doi.org/10.1691/ph.2012.1108
Search in Google Scholar Back to article
25. H. S. Rahman, A. Rasedee, H. H. Othman, M. S. Chartrand, F. Namvar, S. K. Yeap, N. Abdul Samad, R. J. Andas, N. Muhammad Nadzri, T. Anasamy, K. B. Ng and C. W. How, Acute toxicity study of zerumbone-loaded nanostructured lipid carrier on BALB/c mice model, Biomed. Res. Int. 2014 (2014) Article ID 563930 (15 pages); https://doi.org/10.1155/2014/563930417292425276798
Search in Google Scholar Back to article
26. J. Y. Fang, C. L. Fang, C. H. Liu and Y. H. Su, Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC), Eur. J. Pharm. Biopharm. 70(2) (2008) 633–640; https://doi.org/10.1016/j.ejpb.2008.05.00818577447
Search in Google Scholar Back to article
27. L. P. Mendes, J. M. F. Delgado, A. D. A. Costa, M. S. Vieira, P. L. Benfica, E. M. Lima and M. C. Valadares, Biodegradable nanoparticles designed for drug delivery: the number of nanoparticles impacts on cytotoxicity, Toxicol. in Vitro 29(6) (2015) 1268–1274; https://doi.org/10.1016/j.tiv.2014.12.02125596133
Search in Google Scholar Back to article
28. N. V. Shah, A. K. Seth, R. Balaraman, C. J. Aundhia, R. A. Maheshwari and G. R. Parmar, Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: Design and in vivo study, J. Adv. Res. 7(3) (2016) 423–434; https://doi.org/10.1016/j.jare.2016.03.002485683627222747
Search in Google Scholar Back to article
29. A. Beloqui, M. Á. Solinís, A. R. Gascón, A. del Pozo-Rodríguez, A. des Rieux and V. Préat, Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier, J. Control. Release 166(2) (2013) 115–123; https://doi.org/10.1016/j.jconrel.2012.12.02123266764
Search in Google Scholar Back to article
30. A. Ali Khan, J. Mudassir, N. Mohtar and Y. Darwis, Advanced drug delivery to the lymphatic system: lipid-based nanoformulations, Int. J. Nanomedicine 8(1) (2013) 2733–2744; https://doi.org/10.2147/IJN.S41521373220123926431
Search in Google Scholar Back to article
31. X. Zhou, X. Zhang, Y. Ye, T. Zhang, H. Wang, Z. Ma and B. Wu, Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption, Int. J. Pharm. 479(2) (2015) 391–398; https://doi.org/10.1016/j.ijpharm.2014.12.06825556104
Search in Google Scholar Back to article
32. R. Ghadi and N. Dand, BCS class IV drugs: Highly notorious candidates for formulation development, J. Control. Release 248 (2017) 71–95; https://doi.org/10.1016/j.jconrel.2017.01.01428088572
Search in Google Scholar Back to article
33. V. Makwana, R. Jain, K. Patel, M. Nivsarkar and A. Joshi, Solid lipid nanoparticles (SLN) of efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach, Int. J. Pharm. 495(1) (2015) 439–446; https://doi.org/10.1016/j.ijpharm.2015.09.01426367780
Search in Google Scholar Back to article

Diethylene glycol monoethyl ether-mediated nanostructured lipid carriers enhance trans-ferulic acid delivery by Caco-2 cells superior to solid lipid nanoparticles

Abstract

Paradigm

My account